AA
DNTH icon

ALPS Advisors’s Dianthus Therapeutics DNTH Stock Holding History

ALPS Advisors’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.39M Buy
55,281
+19,075
+53% +$1.67M 0.03% 261
2026
Q1 		$3.04M Buy
36,206
+1,000
+3% +$57.9K 0.01% 331
2025
Q4 		$1.45M Buy
35,206
+19,575
+125% +$759K 0.01% 463
2025
Q3 		$615K Sell
15,631
-1,735
-10% -$44.3K ﹤0.01% 632
2025
Q2 		$324K Sell
17,366
-6,318
-27% -$119K ﹤0.01% 910
2025
Q1 		$430K Sell
23,684
-248
-1% -$5.47K ﹤0.01% 612
2024
Q4 		$522K Buy
23,932
+1,635
+7% +$42K ﹤0.01% 596
2024
Q3 		$610K Sell
22,297
-618
-3% -$17.2K ﹤0.01% 587
2024
Q2 		$593K Buy
+22,915
New +$551K ﹤0.01% 554
2022
Q2 		– Sell
-3,777
Closed -$175K – 1049
2022
Q1 		$175K Sell
3,777
-474
-11% -$25.9K ﹤0.01% 810
2021
Q4 		$301K Sell
4,251
-235
-5% -$23.6K ﹤0.01% 831
2021
Q3 		$523K Buy
4,486
+484
+12% +$56.4K 0.01% 491
2021
Q2 		$626K Sell
4,002
-1,488
-27% -$273K 0.01% 489
2021
Q1 		$1.04M Buy
5,490
+39
+0.7% +$6.56K 0.01% 395
2020
Q4 		$684K Buy
5,451
+1,605
+42% +$182K 0.01% 435
2020
Q3 		$418K Buy
3,846
+480
+14% +$56.9K 0.01% 484
2020
Q2 		$405K Buy
+3,366
New +$474K 0.01% 481
2019
Q4 		– Sell
-4,833
Closed -$793K – 826
2019
Q3 		$793K Sell
4,833
-209
-4% -$39.7K 0.01% 346
2019
Q2 		$1.19M Buy
+5,042
New +$1.25M 0.01% 291

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

ALPS Advisors's DNTH Position: Q2 2026 in Review

ALPS Advisors increased its Dianthus Therapeutics (DNTH) stake by 53% in Q2 2026, buying an estimated $1.67M and bringing the position to 55,281 shares worth $5.39M. The position accounts for 0.03% of the portfolio, ranked #261.

ALPS Advisors first reported a position in DNTH in Q2 2019 and has held it in 19 quarters since. 270 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.

  • ALPS Advisors held 55,281 shares of Dianthus Therapeutics worth $5.39M as of Q2 2026.
  • ALPS Advisors bought 19,075 Dianthus Therapeutics shares in Q2 2026, an estimated $1.67M.
  • Dianthus Therapeutics made up 0.03% of ALPS Advisors's portfolio in Q2 2026, its #261 holding.
  • ALPS Advisors first reported a position in Dianthus Therapeutics in Q2 2019 and has held it in 19 quarters since.
  • 270 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.

Based on ALPS Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.